Corrigendum to "Triazolo[4,5-d]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells" [Comput. Struct. Biotechnol. J. 16 (2018) 350-360].,Computational and Structural Biotechnology Journal

当前位置： X-MOL 学术 › Comput. Struct. Biotechnol. J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Corrigendum to "Triazolo[4,5-d]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells" [Comput. Struct. Biotechnol. J. 16 (2018) 350-360].
Computational and Structural Biotechnology Journal ( IF 4.4 ) Pub Date : 2020-05-05 , DOI: 10.1016/j.csbj.2020.04.016
Lea Lough _{1,

2} , Dan Sherman _{1,

2} , Manuel Becerra-Flores _{1,

2} , Deepika Vasudevan _{1,

2} , Olga Lavinda _{1,

2} , Eric Ni _{1,

2} , Hong Wang _{1,

2} , Hyung Don Ryoo _{1,

2} , Raoul Tibes _{1,

2} , Timothy Cardozo _{1,

2}

Affiliation

[This corrects the article DOI: 10.1016/j.csbj.2018.09.003.].

中文翻译：